Efdoralprin alfa

N/A

Report date: 2025/09/26 15:48:18

Base Information

Drug NameEfdoralprin alfa
Drug Alias Namerecombinant human alpha-1 antitrypsin (AAT) Fc fusion protein (Inhibrx)INBRX-101AT-292rhAAT-FcAAT-IgG-Fc +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAlpha-1-antiproteinase replacements
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsEmphysemaalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenPoland +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInhibrxArecor Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInhibrx Biosciences IncLigand Pharmaceuticals IncSanofi +[4] 
Inactive CompaniesN/A
Active IndicationsEmphysemaalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A